Free Trial

Iambic Therapeutics (IAM) Earnings Date, Estimates & Call Transcripts

Iambic Therapeutics logo
$11.51 -1.59 (-12.14%)
As of 10:28 AM Eastern

Iambic Therapeutics Earnings Summary

Iambic Therapeutics released Q3 2026 earnings on November 16, 2026, reporting an EPS of -$6.23, which missed the consensus estimate of -$0.33 by $5.90. With a trailing EPS of $0.00, Iambic Therapeutics' earnings are expected to decrease next year, from ($1.83) to ($2.83) per share.

Nov. 16 Earnings Resources

Consensus EPS
(Nov. 16)
-$0.33
Actual EPS
(Nov. 16)
-$6.23 Missed By -$5.90
Get Iambic Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Iambic Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Iambic Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($1.83) EPS
Next Year EPS Consensus Estimate
($2.83) EPS

Iambic Therapeutics Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/16/2026--$0.33-$6.23 -$5.90-$8.52--

Iambic Therapeutics Earnings - Frequently Asked Questions

Iambic Therapeutics (NASDAQ:IAM) last announced its quarterly earning data on Monday, November 16, 2026. Learn more on IAM's earnings history.

In the previous quarter, Iambic Therapeutics (NASDAQ:IAM) missed the analysts' consensus estimate of ($0.33) by $5.90 with a reported earnings per share (EPS) of ($6.23). Learn more on analysts' earnings estimate vs. IAM's actual earnings.

Iambic Therapeutics' earnings are expected to decrease from ($1.83) per share to ($2.83) per share in the next year.


Earnings data for NASDAQ:IAM is sourced from Fiscal.ai, with the most recent quarter reported on 11/16/2026. New results are added as companies report their earnings.
From Our Partners